Entrada Therapeutics, Inc.
NASDAQ:TRDA
13.65 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -6.685 | -94.616 | -51.158 | -26.523 | -5.1 |
| Depreciation & Amortization
| 2.841 | 1.895 | 1.117 | 0.326 | 0.104 |
| Deferred Income Tax
| 2.805 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 13.111 | 9.895 | 2.526 | 0.325 | 0.294 |
| Change In Working Capital
| 136.315 | -11.111 | -3.421 | 0.282 | 0.174 |
| Accounts Receivables
| -5.878 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.805 | 5.287 | -0.715 | 0.631 | 0.367 |
| Other Working Capital
| 144.998 | -16.398 | -2.706 | -0.349 | -0.193 |
| Other Non Cash Items
| -8.584 | 0.151 | 0.074 | 0.02 | -6.273 |
| Operating Cash Flow
| 139.803 | -93.786 | -50.862 | -25.57 | -10.801 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -5.614 | -2.887 | -4.58 | -2.325 | -0.63 |
| Acquisitions Net
| 0 | 145.763 | 0 | 0.007 | 0 |
| Purchases Of Investments
| -407.207 | -221.977 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 274.426 | 76.214 | 0 | 0 | 0 |
| Other Investing Activites
| -132.781 | -145.763 | 0 | 0 | 0 |
| Investing Cash Flow
| -138.395 | -148.65 | -4.58 | -2.318 | -0.63 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 21.037 | 0.479 | 190.691 | 50.089 | 0.038 |
| Common Stock Repurchased
| 0.443 | 0.284 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 21.037 | 0.479 | 116.77 | 50.089 | 0.038 |
| Financing Cash Flow
| 21.037 | 0.479 | 307.461 | 50.089 | 0.038 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 22.445 | -241.957 | 252.019 | 22.201 | -11.393 |
| Cash At End Of Period
| 67.602 | 49.107 | 291.064 | 39.045 | 16.844 |